Comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 vs 3q13 Microdeletion Syndrome C2931338
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetal Androgens Excess and 3q13 Microdeletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
A condition where an XX fetus produces excess male hormones, often from adrenal gland abnormalities, leading to atypical genital development. It is identified at birth. Treatment typically includes hormone therapy and possible surgery.
3q13 Microdeletion Syndrome C2931338
A genetic disorder from missing material on chromosome 3q13, associated with developmental delays, intellectual disability, and various congenital features.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
0-0
3q13 Microdeletion Syndrome C2931338
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
severe
3q13 Microdeletion Syndrome C2931338
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
Chronic
3q13 Microdeletion Syndrome C2931338
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
No
3q13 Microdeletion Syndrome C2931338
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
reproductive
3q13 Microdeletion Syndrome C2931338
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
endocrine
3q13 Microdeletion Syndrome C2931338
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetal-androgens-excess-C5680189 and 3q13-microdeletion-syndrome-C2931338 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 3q13 Microdeletion Syndrome C2931338 | Discriminating power |
|---|---|---|---|
| Genital appearance | Atypical genital development may be recognized at birth from fetal androgen excess. | Genital atypicality is not a defining feature in the supplied description. | High |
| Development | Developmental delay is not established by the source description. | Developmental delay and intellectual disability are associated features. | High |
| Congenital pattern | Mainly reproductive and endocrine findings, often linked to adrenal abnormality. | Broader congenital features may occur, but the exact pattern is variable. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 when
XX infant with atypical genitalia
This pattern fits fetal androgen excess better than a 3q13 deletion.
High
Suspected adrenal source
The source specifically links excess androgens to adrenal abnormalities.
Moderate
Endocrine rather than chromosomal concern
The supplied category is endocrine, although genetic testing may still be needed.
Moderate
Choose 3q13 Microdeletion Syndrome C2931338 when
Developmental delay with congenital anomalies
These features align with the described microdeletion syndrome.
High
Chromosomal microarray suspicion
A missing 3q13 segment is a genetic finding requiring laboratory confirmation.
High
No dominant genital-androgen presentation
Absence of that pattern makes the left diagnosis less likely, but does not exclude it.
Low
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 3q13 Microdeletion Syndrome C2931338 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome study | 46,XX is part of the named condition. | Sex chromosomes are not specified by the source. | A 46,XX result supports the left label only with compatible clinical findings. |
| Chromosomal microarray | A 3q13 deletion is not expected from the description. | May identify missing material at 3q13. | A confirmed deletion supports the right condition; clinical correlation remains necessary. |
| Endocrine evaluation | Androgen excess and possible adrenal abnormality are central considerations. | No specific endocrine abnormality is established here. | Abnormal hormone results are findings, not a complete diagnosis, and need specialist interpretation. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
- Outcome
- Long-term outcome is not established here and depends on the underlying adrenal or endocrine cause and care.
- Factors
- Cause, endocrine control, and individualized treatment decisions.
3q13 Microdeletion Syndrome C2931338
- Outcome
- Outcome is variable and not quantified in the source; developmental and congenital features may persist.
- Factors
- Deletion extent, associated anomalies, and developmental support.
Time frame: Both are described as chronic; exact timelines are not established.
Accurate diagnosis, specialist follow-up, and individual clinical findings.
Complications comparison
| Complication | Presentation |
|---|---|
| Adrenal-related illness | Possible if an adrenal disorder causes androgen excess; exact risk is not supplied. Not established by the source description. Urgent adrenal symptoms require clinician assessment; no cutoff or treatment dose is implied. |
| Neurodevelopmental needs | Not established as a core feature. Developmental delay and intellectual disability may require long-term support. Severity and educational needs vary and should be assessed individually. |
| Surgical or hormonal decisions | Hormone therapy and possible surgery are described, but choices are individualized. No specific surgical or hormonal pathway is established here. Shared decision-making and specialist care are essential. |
Patient education highlights
- HighDifferent causes
One condition involves fetal androgen excess in an XX fetus; the other involves missing chromosome 3q13 material.
- HighTesting limits
An abnormal test result is not automatically a diagnosis and should be interpreted by a clinician.
- MediumCare planning
Both can be chronic, but support needs differ and should be tailored after confirmed evaluation.